IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 348 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,578,000 | +260.3% | 42,634 | +450.5% | 0.08% | +162.5% |
| Q4 2020 | $438,000 | -92.0% | 7,744 | -93.3% | 0.03% | -82.1% |
| Q3 2020 | $5,492,000 | -25.2% | 115,751 | -7.1% | 0.18% | -5.8% |
| Q2 2020 | $7,345,000 | +88.6% | 124,569 | +51.2% | 0.19% | +84.5% |
| Q1 2020 | $3,894,000 | -47.1% | 82,360 | -32.4% | 0.10% | 0.0% |
| Q4 2019 | $7,362,000 | +346.5% | 121,864 | +342.8% | 0.10% | +442.1% |
| Q3 2019 | $1,649,000 | +254.6% | 27,524 | +280.3% | 0.02% | +111.1% |
| Q2 2019 | $465,000 | – | 7,238 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,529,838 | $404,393,000 | 11.39% |
| DOWLING & YAHNKE LLC | 676,379 | $41,888,000 | 5.27% |
| Opus Point Partners Management, LLC | 102,459 | $6,345,000 | 4.19% |
| WILLIAM HARRIS INVESTORS INC | 230,443 | $14,271,000 | 3.43% |
| PINNACLE ASSOCIATES LTD | 1,690,263 | $104,678,000 | 2.20% |
| MESSNER & SMITH THEME VALUE INVESTMENT MANAGEMENT LTD /CA/ | 21,298 | $1,319,000 | 2.11% |
| Sonora Investment Management, LLC | 126,763 | $7,850,000 | 2.04% |
| Virtus ETF Advisers LLC | 10,447 | $647,000 | 1.78% |
| Apex Capital Management | 1,020,096 | $63,175,000 | 1.41% |
| PERKINS CAPITAL MANAGEMENT INC | 19,900 | $1,232,000 | 1.32% |